As the COVID-19 situation evolves we’re continuing to work hard to safeguard the health and safety of all our employees and to provide continuity to our clients. We are confident that the plans we have put in place and the steps already taken, will ensure that we have maximum resource availability to deliver our clients’ project work. As always, we are a forward looking organisation and our objective is to assist our clients to be competitively positioned for the post-COVID-19 world.
We help you transform possibilities into successful products, combining expertise in science and technology with our love of invention and problem solving. It’s a constant challenge – and one we relish. Our flexible, collaborative approach, broad market knowledge and unwavering commitment to quality mean that we can solve the most complex R&D challenges and quickly deliver tangible benefits to your business.
Working
across the
innovation
lifecycle
across the
innovation
lifecycle
Technologies
Sagentia specialises in solving complex problems by bringing together the fundamentals of science with the pragmatism and application of engineering to create ground breaking products.
Markets
Our scientists and engineers redefine what’s possible and help R&D groups across the medical, industrial, oil & gas and consumer sectors achieve commercial return from their most complex technology projects.
Insights
Addressing the Point of Care sample preparation challenge
Diagnostic product development advice from Sagentia’s Nick Collier and Carl Hewett Continued innovation in Point of care...
What’s next on the Point-of-Care Testing Menu?
From SARS-CoV-2 to cardiac biomarkers, a steady stream of IVD innovation shows no signs of letting up Article published in...
Improving dialysis in the home
By Chris Humby, Vice-President Medical at Sagentia Statistics surrounding chronic kidney disease (CKD) make sobering reading...
